Seyyal ROTA, Buğra Adil BUYRUKÇU, Gülendam BOZDAYI, Ayşegül YÜCEL

Gebe kadınlarda CMV IgG avidite ve CMV IgM sonuçlarının karşılaştırılması

Amaç: Gebelerde CMV IgM ile CMV IgG avidite sonuçlan arasındaki ilişkinin belirlenmesi. Materyal-Metod: 68 gebe kadında serumda CMV IgM (MEIA ve ELI-SA) ve CMV IgG (MEIA) ve 2 kadında CMV PCR çalışıldı. Sonuçlar: CMV IgM MEIA ile 47, ELISA ile 24 hastada şüpheli negatif/pozitif ve pozitif sonuçlar almdı. CMV IgG avidite sonucu 6 hastada "şüpheli sınırlarda (%25-35)", 6 hastada "düşük (

Comparison of the results of CMV IgG avidity and CMV IgM in pregnant women

Aim: To assess the association between the results of CMV IgM and CMV IgG avidity tests in pregnant women. Materials and Methods: CMV IgM (MEIA and ELISA), CMV IgG (MEIA) and CMV IgG avidity tests were performed in 68 pregnant women, and CMV PCR was studied in 2 of them. Results: CMV IgM gave suspicious negativity, suspicious positivity and positivity in 47 women with MEIA and in 24 women with ELISA. CMV IgG avidity results were in the gray zone (25%-35%) in 6 women and showed low avidity in 6. In both groups, CMV IgM positivity was 33.3% with both MEIA and ELISA; however, the rates of negativity, suspicious negativity and suspicious positivity varied. In the first group, the rates were 0%, 33.3%, and 33.3% with MEIA, and 50%, 16.7%, and 0% with ELISA, respectively. In the second group, the rates were 16.7%, 33.3%, and 16.7% with MEIA, and 66.7%, 0%, and 0% with ELISA. CMV PCR was performed in 2 women with low CMV IgG avidity and both were positive. Discussion: The results of CMV IgM ELISA and CMV IgM MEIA, whi¬ch work by opposite systems, may be conflicting. In order not to miss any CMV infection in pregnant women, CMV IgM should be studied with both methods and whenever suspicious negativity, suspicious positivity or positivity are found as well as positivity of CMV IgG, the CMV IgG avidity test should be performed. A low avidity index indicates primary infection. PCR may be used to confirm the presence of the virus.

PDF

___

1. Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, Jahn G. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 1995; 76: 741-750.
2. Revello MG, Gerna G. Diagnosis and management of Human Cytomegalovirus infection in the mother, fetus and newborn infant. Clin Microbiol Rev 2002; 15 (4): 680-715.
3. Boppana BSB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999; 104: 55-60
4. Stagno S. Cytomegalovirus. In: Remington JS ve Klein JO (ed): Infectious diseases of the fetus and newborn infant. Philadelphia: W. B. Saunders Co.; 2001, sy 389-424.
5. Stagno S, Whitley RJ. Herpesvirus infection of pregnancy. N Engl J Med 1985;3B: 1270-1274.
6. Fowler K B, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326: 663-667.
7. Griffiths PD, McLean A, Emery VC. Encouraging prospects for immunization against primary cytomegalovirus infection. Vaccine 2001; 19: 1356-1362.
8. Hayes K, Gibas H. Placental cytomegalovirus infection without fetal involvement following primary infection in pregnancy. J Pediatr 1971; 79: 401-405.
9. Revello MG, Percivalle E, Zannino M, Rossi V, Gerna G. Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein. J Virol Methods 1991; 35: 315-329.
10. Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S, Landini MR Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol 1997; 4: 469-473.
11. Immunology. In: Isenberg HD (ed): Clinical Microbiology Procedures Handbook. Vol II. New York : ASM, 1992, sy 9.1.1.
12. Sia IG, Wilson JA, Groettum C, Epsy MJ, Smith TF, Paya CV. Cytomegalovirus DNA load predicts relapsing CMV infection after solid organ transplantation J Infect Dis 2000; 181: 717-720.